
Journal of Medicinal Chemistry p. 1181 - 1187 (1985)
Update date:2022-07-29
Topics:
Wissner, A.
Schaub, R. E.
Sum, P.-E.
Kohler, C. A.
Goldstein, B. M.
Racemic analogues of platelet activating factor (PAF) that contain a methylene group between the C2 and C3 carbon atoms (39) or between the C1 and C2 carbon atoms (40) have been synthesized.These compounds show reduced platelet aggregation and hypotensive activity as measured against racemic C16 PAF.Compounds in which the C1 carbon atom of PAF is substituted with one or two methyl groups (41 and 42, respectively) or the C3 carbon is substituted with a single methyl group (43) have been synthesized.Platelet aggregation and hypotensive responses producedby these compounds are significantly less than those obtained with racemic C16 PAF.None of the above compounds exhibit a separation of the platelet aggregation and hypotensive activities.
View MoreShenyang Mole pharmaceutical Technology Development Co.,Ltd
Contact:+86-24-31204918/13889278616
Address:No.44, wanliutang road, shenhe District of Shenyang
ShangHai Original Economy-Trade Develop Co.,Ltd.,
Contact:86-21-68552131
Address:shanghai
Contact:+1-973-357-0577
Address:10 Taft Rd.
Nantong Kaixin Pharma Chemical Co.,Ltd.
Contact:86-513-85250786
Address:2-1103 Huachen Mansion, 111 Gongnong Road,Nantong, Jiangsu, China
Shandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
Doi:10.1016/S0040-4039(00)99436-X
(1989)Doi:10.1016/S0040-4039(00)98325-4
(1985)Doi:10.1016/S0040-4039(00)94769-5
(1985)Doi:10.1246/cl.1985.441
(1985)Doi:10.1016/S0040-4020(01)86888-5
(1987)Doi:10.1515/bchm2.1960.320.1.218
(1960)